According to the "14th Five-Year Plan" for the Development of Pharmaceutical Industry, the total assets of China's pharmaceutical manufacturing industry have exceeded 4.5 trillion yuan, with broad prospects for development, but also facing more technical challenges. Zhu Yuelian, vice president and chief scientist of Shanxi Guorun Pharmaceutical Co LTD, said medical research and drug production are closely linked today, and promoting the coordinated development of the two will become a new way to push the entire pharmaceutical industry to break bottlenecks.
As a well-known medical doctor, Zhu Yuelian leads Guorun Pharmaceutical to focus on the two goals of "disease drug treatment" and "disease prevention", to guide production and research and development from the perspectives of internal management and external cooperation, and to supervise the implementation of mid - and long-term new drug research and development plan. And with a series of pioneering research strategies, the organic combination of medical concepts and drug research, constantly explore the way for pharmaceutical innovation and integrated development, and promote the improvement of people's health with exquisite medical technology.
Zhu Yuelian, who is also the director of Research and Development Department of Guorun Pharmaceutical, always actively guides the company to carry out efficient drug research and development work, and integrates her own medical research results into the actual manufacturing of public drugs. While fully expanding the company's drug categories and production capacity, Guorun Pharmaceutical has ensured both the quality and output of its products, making its drug products recognized by the market and medical seekers. Guorun Pharmaceutical has also been recognized as "Shanxi Province Specialized, special and new Enterprise" and "Shanxi Province High-tech Enterprise" relying on its high technological advantages and production quality. Not only that, her outstanding strength level and industry contribution is also recognized by all. With her rich medical attainments, she led the company to participate in the formulation of national standards for "caffeine citrate injection", "acetyl cysteine solution for inhalation", "acetyl cysteine injection" and other drugs, guiding and promoting the standardization of pharmaceutical enterprises. It has made outstanding contributions to the high-quality development of the industry.
The pharmaceutical industry is a high-tech industry with high added value and social benefits. The value of medical progress and drug innovation to life science is self-evident. Zhu Yuelian, who has a strong sense of medical mission and social responsibility, has been overcoming difficulties and climbing the peak in medical scientific research. Through in-depth research and analysis, she published an academic paper entitled "Mechanism of Action of Dorsal root Reflex in Inflammatory Pain and its Research Progress" in the Journal of Medical Research, creatively integrating the mechanism of dorsal root reflex into the explanation of the process of inflammatory pain, which is an important neuromedical research discovery. It provides a new solution for the diagnosis and treatment of inflammation pain in human body.
The medical industry has a long way to go, and there is no end to medical exploration. Zhu Yuelian said that the next step will continue to improve the depth of integration of medical scientific research achievements and drug research and production, strengthen the industry-university-research-medical technology collaboration, integrate and gather medical innovation resources, and build Guorun Pharmaceutical into a national manufacturing innovation center. At the same time, it will continue to study the spirit of the industry key generic technology research, with a rigorous scientific attitude to strengthen the standardization of the pharmaceutical industry, the implementation of standards and active supervision, improve the quality of pharmaceutical products, for the world pharmaceutical industry to improve and upgrade and promote solid support.
